X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1733) 1733
Publication (106) 106
Book Review (95) 95
Newsletter (13) 13
Book Chapter (6) 6
Conference Proceeding (5) 5
Book / eBook (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1702) 1702
humans (1418) 1418
adenoma - enzymology (878) 878
male (787) 787
female (775) 775
middle aged (574) 574
animals (498) 498
adult (470) 470
oncology (449) 449
adenoma - pathology (437) 437
aged (417) 417
immunohistochemistry (323) 323
cancer (277) 277
colorectal neoplasms - enzymology (277) 277
expression (235) 235
mice (234) 234
abridged index medicus (230) 230
adenoma - genetics (217) 217
tumors (199) 199
adenocarcinoma - enzymology (195) 195
rats (194) 194
pathology (193) 193
adenoma (184) 184
endocrinology & metabolism (181) 181
aged, 80 and over (172) 172
thyroid neoplasms - enzymology (166) 166
carcinoma - enzymology (165) 165
adenoma - metabolism (152) 152
colorectal cancer (151) 151
colonic neoplasms - enzymology (147) 147
colorectal neoplasms - pathology (138) 138
cells (137) 137
carcinoma (130) 130
intestinal mucosa - enzymology (129) 129
adenomas (121) 121
colorectal neoplasms - genetics (115) 115
cyclooxygenase 2 (114) 114
pituitary neoplasms - enzymology (113) 113
histocytochemistry (106) 106
isoenzymes - metabolism (106) 106
gene expression regulation, neoplastic (101) 101
membrane proteins (101) 101
gastroenterology & hepatology (100) 100
adolescent (99) 99
adenocarcinoma - pathology (98) 98
adenoma - chemically induced (98) 98
mutation (96) 96
carcinogenesis (94) 94
cell biology (91) 91
liver - enzymology (90) 90
apoptosis (89) 89
biochemistry & molecular biology (89) 89
carcinoma - pathology (88) 88
thyroid gland - enzymology (86) 86
colon-cancer (85) 85
immunoenzyme techniques (83) 83
gene (80) 80
colonic neoplasms - pathology (79) 79
colon - enzymology (78) 78
reverse transcriptase polymerase chain reaction (77) 77
rna, messenger - metabolism (77) 77
liver neoplasms - enzymology (75) 75
gene-expression (74) 74
enzymes (73) 73
gene expression (73) 73
colorectal-cancer (72) 72
tumor cells, cultured (71) 71
article (70) 70
case-control studies (70) 70
thyroid neoplasms - pathology (70) 70
biomarkers, tumor - analysis (69) 69
disease progression (68) 68
hyperplasia (68) 68
adrenal cortex neoplasms - enzymology (67) 67
polymerase chain reaction (67) 67
risk factors (67) 67
prostaglandin-endoperoxide synthases - metabolism (66) 66
genetic aspects (65) 65
precancerous conditions - enzymology (65) 65
biomarkers, tumor - metabolism (63) 63
colorectal adenomas (63) 63
gene expression regulation, enzymologic (63) 63
mice, inbred c57bl (63) 63
blotting, western (61) 61
activation (60) 60
adenoma, islet cell - enzymology (60) 60
pancreatic neoplasms - enzymology (60) 60
prognosis (60) 60
risk (60) 60
surgery (60) 60
research (59) 59
rna, messenger - genetics (58) 58
metastasis (57) 57
neoplasm invasiveness (57) 57
nonsteroidal antiinflammatory drugs (57) 57
proteins (57) 57
adrenal gland neoplasms - enzymology (56) 56
breast-cancer (56) 56
colon (56) 56
familial adenomatous polyposis (56) 56
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1617) 1617
German (33) 33
Russian (29) 29
Japanese (20) 20
French (16) 16
Polish (8) 8
Chinese (7) 7
Italian (7) 7
Spanish (7) 7
Dutch (3) 3
Norwegian (2) 2
Hungarian (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrine-Related Cancer, ISSN 1351-0088, 03/2010, Volume 17, Issue 1, pp. 27 - 37
Journal Article
Journal Article
Histopathology, ISSN 0309-0167, 12/2017, Volume 71, Issue 6, pp. 985 - 988
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2007, Volume 170, Issue 2, pp. 693 - 708
Little is known about how the composition of stromal cells within the lung cancer microenvironment varies during tumor progression. We examined by... 
Pathology | GROWTH-INHIBITION | COLONY-STIMULATING FACTOR | ARGINASE-I | ANGIOGENESIS | NITRIC-OXIDE SYNTHASE | INFLAMMATION | MAST-CELLS | RECEIVING URETHAN | PATHOLOGY | QUANTITATIVE-ANALYSIS | CANCER | Fibroblasts - enzymology | Adenocarcinoma - pathology | Macrophages, Alveolar - pathology | Lung Neoplasms - chemically induced | Adenocarcinoma - chemically induced | Lung Neoplasms - pathology | Male | Bone Marrow - enzymology | Cell Transformation, Neoplastic - chemically induced | Carcinogens - toxicity | Lung - enzymology | Adenoma - enzymology | Monocytes - pathology | Biomarkers, Tumor - metabolism | Adenoma - blood supply | Lung Neoplasms - blood supply | Adenoma - diagnosis | Lung - pathology | Lung Neoplasms - enzymology | Adenocarcinoma - enzymology | Fibroblasts - pathology | Mast Cells - enzymology | Cell Transformation, Neoplastic - metabolism | Adenocarcinoma - blood supply | Macrophage Activation | Macrophages, Alveolar - enzymology | Monocytes - enzymology | Adenocarcinoma - diagnosis | Animals | Signal Transduction - drug effects | Urethane - toxicity | Bone Marrow - pathology | Mast Cells - pathology | Adenoma - pathology | Mice | Cell Transformation, Neoplastic - pathology | Lung Neoplasms - diagnosis | Adenoma - chemically induced | Nitric Oxide Synthase Type II - metabolism | Index Medicus | Abridged Index Medicus | Regular
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 19, Issue 5, pp. 629 - 639
The human gene , which encodes the tyrosine phosphatase Shp2, may act as a proto-oncogene because dominantly activating mutations have been detected in several... 
BREAST-CANCER | CELLS | ACTIVATION | HUMAN-DISEASE | ONCOLOGY | SHP2 TYROSINE PHOSPHATASE | INFLAMMATION | STAT3 | LIVER | MUTATIONS | DIFFERENTIATION | CELL BIOLOGY | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | Carcinoma, Hepatocellular - chemically induced | Liver - pathology | Hepatitis - enzymology | Liver - enzymology | Carcinoma, Hepatocellular - prevention & control | Humans | Hyperplasia | Lipopolysaccharides - administration & dosage | Adenoma, Liver Cell - pathology | Liver Neoplasms - chemically induced | Male | Necrosis | Liver - drug effects | Time Factors | Tumor Suppressor Proteins - deficiency | Carcinoma, Hepatocellular - genetics | Diethylnitrosamine | Hepatitis - genetics | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - deficiency | Tumor Suppressor Proteins - genetics | STAT3 Transcription Factor - deficiency | Liver Neoplasms - pathology | Adenoma, Liver Cell - enzymology | Liver Neoplasms - enzymology | Cytokines - genetics | Interleukin-6 - administration & dosage | Adenoma, Liver Cell - genetics | STAT3 Transcription Factor - genetics | Cytokines - blood | Liver Neoplasms - prevention & control | Liver Regeneration | Tumor Suppressor Proteins - metabolism | Liver Neoplasms - genetics | Signal Transduction | Mice, Inbred C57BL | Gene Expression Regulation | Inflammation Mediators - blood | Hepatitis - pathology | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - analysis | Carcinoma, Hepatocellular - enzymology | Mice, Knockout | Animals | Carcinoma, Hepatocellular - pathology | Mice | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Tyrosine | Liver cancer | Development and progression | Phosphatases | Leukemia | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 08/2012, Volume 31, Issue 32, pp. 3679 - 3695
Colitis-associated colorectal cancers are an etiologically distinct subgroup of colon cancers that occur in individuals suffering from inflammatory bowel... 
intestinal barrier | inflammatory bowel disease | colon carcinogenesis | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEPATOCYTE GROWTH-FACTOR | ULCERATIVE-COLITIS | BARRIER FUNCTION | INTESTINAL HOMEOSTASIS | PLASMINOGEN ACTIVATION | CELL BIOLOGY | MATRIX METALLOPROTEINASES | INFLAMMATORY-BOWEL-DISEASE | ONCOLOGY | COLORECTAL-CANCER | MOUSE MODEL | GENETICS & HEREDITY | SERINE-PROTEASE MATRIPTASE | Adenocarcinoma - pathology | Cell Proliferation | Epithelium - enzymology | Humans | Gene Expression Regulation, Neoplastic | Colitis - pathology | Mice, 129 Strain | Intestinal Absorption | Adenoma - enzymology | Inflammatory Bowel Diseases - enzymology | Inflammatory Bowel Diseases - pathology | Serine Endopeptidases - genetics | Basement Membrane - enzymology | Genes, Tumor Suppressor | Metagenome - drug effects | Epithelium - metabolism | Signal Transduction | Colon - pathology | Neoplasm Invasiveness | Mice, Inbred C57BL | Adenocarcinoma - enzymology | Basement Membrane - metabolism | Cell Transformation, Neoplastic - metabolism | beta Catenin - metabolism | Mice, Knockout | Gene Expression Regulation, Enzymologic | Membrane Proteins | Animals | Colitis - enzymology | Colitis - microbiology | Colonic Neoplasms - pathology | Inflammatory Bowel Diseases - microbiology | Anti-Bacterial Agents - pharmacology | Colonic Neoplasms - enzymology | Mice | Serine Endopeptidases - metabolism | Precancerous Conditions | Colon cancer | Immune response | Research | Carcinogenesis | Analysis | Stem cells | Inflammatory bowel disease | Proteins | Gene expression | Pathogenesis | Colorectal cancer | Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 3, pp. 529 - 537
Background and Aims Glycogen storage disease type 1a (GSD1a) is an inherited disease caused by a deficiency in the catalytic subunit of the glucose-6... 
Gastroenterology and Hepatology | Glycogen storage disease | Hepatic steatosis | Endogenous glucose production | Glucose-6 phosphatase | Hepatic adenomas | PHOSPHATIDYLINOSITOL 3-KINASE | RAT SMALL-INTESTINE | MECHANISMS | HEPATOCELLULAR-CARCINOMA | THERAPY | G6PC GENE | MOUSE MODEL | GENE-EXPRESSION | GASTROENTEROLOGY & HEPATOLOGY | GLUCOSE-PRODUCTION | Hepatomegaly - pathology | Glucose-6-Phosphatase - genetics | Adenoma, Liver Cell - etiology | Liver - enzymology | Fatty Liver - pathology | Hepatomegaly - enzymology | Humans | Adenoma, Liver Cell - pathology | Male | Mice, 129 Strain | Base Sequence | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Female | Adenoma, Liver Cell - enzymology | Liver Neoplasms, Experimental - pathology | Disease Models, Animal | Gene Targeting | Mice, Inbred C57BL | DNA Primers | Gene Knockout Techniques | Liver Neoplasms, Experimental - etiology | Mice, Knockout | Glycogen Storage Disease Type I - enzymology | Animals | Glycogen Storage Disease Type I - genetics | Glucose-6-Phosphatase - antagonists & inhibitors | Liver Neoplasms, Experimental - enzymology | Mice | Glycogen Storage Disease Type I - etiology | Fatty Liver - etiology | Hepatomegaly - etiology | Enzymes | Genetic disorders | Phosphatases | Glycogen | Gastrointestinal diseases | Liver | Diagnostic imaging | Glucose | Fatty acids | Dextrose | Index Medicus | Life Sciences | Neurons and Cognition
Journal Article
Human Pathology, ISSN 0046-8177, 2007, Volume 38, Issue 2, pp. 239 - 246
Journal Article
Human Pathology, ISSN 0046-8177, 07/2016, Volume 53, pp. 153 - 158
An 18-year-old man underwent liver transplantation due to an Abernethy malformation associated with multiple hepatocellular nodules including one which was... 
β-catenin | Hepatocellular adenoma | Abernethy malformation | Hepatocellular carcinoma | Glutamine synthetase | Porto-systemic shunt | Focal nodular hyperplasia | beta-catenin | MARKERS | PATHOLOGY | ADENOMAS | Neoplasms, Multiple Primary - surgery | Liver Transplantation | Humans | Focal Nodular Hyperplasia - diagnosis | Vascular Malformations - enzymology | Male | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Carcinoma, Hepatocellular - genetics | Adenoma, Liver Cell - surgery | Adenoma, Liver Cell - enzymology | Liver Neoplasms - enzymology | Focal Nodular Hyperplasia - surgery | Glutamate-Ammonia Ligase - analysis | Adenoma, Liver Cell - genetics | Focal Nodular Hyperplasia - enzymology | Neoplasms, Multiple Primary - diagnosis | Genetic Predisposition to Disease | Neoplasms, Multiple Primary - genetics | Vascular Malformations - surgery | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Carcinoma, Hepatocellular - diagnosis | Neoplasms, Multiple Primary - enzymology | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Carcinoma, Hepatocellular - enzymology | beta Catenin - genetics | Magnetic Resonance Imaging | Phenotype | Liver Neoplasms - diagnosis | Adenoma, Liver Cell - diagnosis | Biopsy | Focal Nodular Hyperplasia - genetics | Adolescent | Vascular Malformations - diagnosis | Biomarkers, Tumor - genetics | Mutation | Vascular Malformations - genetics | Cell Transformation, Neoplastic - pathology | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2005, Volume 65, Issue 8, pp. 3226 - 3235
The serine/threonine kinase AKT and its downstream mediator mammalian target of rapamycin (mTOR) are activated in lung adenocarcinoma, and clinical trials are... 
CELL LUNG-CANCER | PROSTATE INTRAEPITHELIAL NEOPLASIA | BRONCHIOLOALVEOLAR CARCINOMA | AKT ACTIVATION | ONCOLOGY | C-MYC | TUMOR ANGIOGENESIS | PULMONARY ADENOCARCINOMA | ATYPICAL ADENOMATOUS HYPERPLASIA | INFILTRATING MACROPHAGES | P70 S6 KINASE | Protein Kinases - metabolism | Lung Neoplasms - drug therapy | Macrophages, Alveolar - pathology | Adenoma - genetics | Hyperplasia | Pulmonary Alveoli - enzymology | Precancerous Conditions - drug therapy | Adenoma - enzymology | Adenoma - drug therapy | Pulmonary Alveoli - drug effects | Precancerous Conditions - pathology | Adenocarcinoma - genetics | Protein-Serine-Threonine Kinases - metabolism | Genes, ras - genetics | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Precancerous Conditions - enzymology | Sirolimus - analogs & derivatives | Lung Neoplasms - enzymology | Pulmonary Alveoli - pathology | Adenocarcinoma - enzymology | Adenocarcinoma - drug therapy | Cell Transformation, Neoplastic - metabolism | Precancerous Conditions - genetics | Sirolimus - pharmacology | Disease Progression | Macrophages, Alveolar - enzymology | Proto-Oncogene Proteins c-akt | Animals | Macrophages, Alveolar - drug effects | Adenoma - pathology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | TOR Serine-Threonine Kinases | Cell Transformation, Neoplastic - drug effects | Enzyme Activation | Mutation | Ribosomal Protein S6 Kinases - biosynthesis | Index Medicus
Journal Article
Science, ISSN 0036-8075, 11/2001, Volume 294, Issue 5545, pp. 1343 - 1346
Journal Article